Endonovo Therapeutics Reports Third Quarter 2019 Results
19 nov. 2019 16h35 HE
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Nov. 19, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), announced today its financial results for the quarter ended September 30,...
Cabot Microelectronics Corporation to Participate in Société de Chimie Industrielle Monthly Luncheon
28 oct. 2019 19h00 HE
|
Cabot Microelectronics Corporation
Aurora, IL, Oct. 28, 2019 (GLOBE NEWSWIRE) -- Cabot Microelectronics Corporation (Nasdaq: CCMP), a leading global supplier of consumable materials to semiconductor manufacturers and pipeline...
Sorrento Therapeutics Expands Resiniferatoxin (RTX) Clinical Development Program to Life-Threatening Cardiovascular Diseases With Completion of Major Animal Toxicology Study
15 avr. 2019 04h00 HE
|
Sorrento Therapeutics, Inc.
SAN DIEGO, April 15, 2019 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento"), announced that its Neuro-Therapeutics unit is pursuing clinical development of resiniferatoxin...
Avinger Announces Preliminary Analysis of Results from SCAN Clinical Study
19 déc. 2018 06h00 HE
|
Avinger, Inc.
OCT Imaging with Pantheris Superior or Equivalent to IVUS on all Parameters REDWOOD CITY, Calif., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative...
ARCA biopharma Announces Second Quarter 2018 Financial Results and Provides Corporate Update
09 août 2018 16h15 HE
|
ARCA biopharma, Inc.
WESTMINSTER, Colo., Aug. 09, 2018 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq:ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted...
ARCA Biopharma Announces Issuance of European Patent for Treating Cardiovascular Diseases and Conditions With a New Chemical Entity Utilizing Genetic Targeting
16 nov. 2017 08h30 HE
|
ARCA biopharma, Inc.
WESTMINSTER, Colo., Nov. 16, 2017 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq:ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted...
John Marshall Law School Fraternity Honored, Named 3rd Best in Country
27 janv. 2016 12h39 HE
|
The John Marshall Law School-Chicago
CHICAGO, Jan. 27, 2016 (GLOBE NEWSWIRE) -- The chapter of Phi Alpha Delta (PAD) Law Fraternity at The John Marshall Law School in Chicago recently was named among the top law school fraternities in...
Holy Name Medical Center First in the Northeast to Offer Magellan(TM) Robotic System
19 nov. 2015 06h11 HE
|
Holy Name Medical Center
TEANECK, N.J., Nov. 19, 2015 (GLOBE NEWSWIRE) -- Physicians at Holy Name Medical Center are the first in the Northeast to use the Magellan™ Robotic System, which enables them to perform complex,...
New Platelet Blocker Reduces Blood Clots, Artery-Opening Procedures
20 juin 2012 13h00 HE
|
American Heart Association
Study Highlights:
An investigational platelet-blocking drug reduced the rate of dangerous blood clots in the legs and the need for artery-opening surgery in people with peripheral artery...
American Heart Association Launches Free-Access Online Journal
21 févr. 2012 16h00 HE
|
American Heart Association
News Highlights:
Among findings posted in the inaugural publication of the American Heart Association's online-only, free-access scientific journal:
The NIH Stroke Scale accurately identifies...